Glycemic burden and the risk of adverse hepatic outcomes in patients with chronic hepatitis B with type 2 diabetes
Abstract Background and aims: Type 2 diabetes (T2D…
业务学习
The steatosis-associated fibrosis estimator (SAFE) score: A tool to detect low-risk NAFLD in primary care
Abstract 脂肪变性相关纤维化评估（SAFE）评分：一种在初级保健中检测低风险NAFLD的工具 Back…
Prognostic and therapeutic significance of microbial cell-free DNA in plasma of people with acute decompensation of cirrhosis
Highlights Background & Aims Although the effect of…
Improved prediction of 10-year risk of severe liver disease in the general population using commonly available biomarkers
Abstract Background: Estimating the risk for …
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis
Abstract Objective In retrospective studies, liver…
NAFLD-related hepatocellular carcinoma: The growing challenge
Abstract Hepatocellular carcinoma (HCC) is a …